Phase I evaluation of carfilzomib (PR-171) in hematological malignancies: Responses in multiple myeloma and Waldenstrom's macroglobulinemia at well-tolerated doses Meeting Abstract
| Authors: | Stewart, K. A.; O'Connor, O. A.; Alsina, M.; Trudel, S.; Urquilla, P. R.; Vallone, M. K.; Molineaux, C. J.; Goy, A.; Orlowski, R. Z. |
| Abstract Title: | Phase I evaluation of carfilzomib (PR-171) in hematological malignancies: Responses in multiple myeloma and Waldenstrom's macroglobulinemia at well-tolerated doses |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 441s |
| Language: | English |
| ACCESSION: | WOS:000455043702124 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.8003 |
| Notes: | Meeting Abstract: 8003 -- Source: Wos |
